GLP-1 RAs reduce oxidative stress by decreasing ROS production in cardiomyocytes and by decreasing the circulating levels of 8-iso prostaglandin F2α as well as carotid intima media thickness in T2DM patients [63]. Here, GLP1R is linked to type 2 diabetes mellitus.